ONCOLife Articles
OPTIMAL Data Support TLX597-Tx as a Next-Gen Radioligand Therapy in Prostate Cancer
Clinical Trials | 30 April 2026
AidaBREAST Gains FDA Breakthrough Status for Personalized Radiotherapy in Breast Cancer
FDA & EMA | 29 April 2026
Phase 3 MagnetisMM-5 Trial Supports Earlier Use of Elranatamab in Relapsed Myeloma
Clinical Trials | 29 April 2026
Real-World Analysis Links Community Oncology Care to Longer Survival in Multi-Cancer
ONCOLife | 28 April 2026
Early CAR T-Cell Intervention Shows Disease-Eradication Potential in High-Risk Myeloma
ONCOLife | 24 April 2026
World’s First Nectin-4-Targeting ADC Enters Phase III Trial in Triple-Negative Breast Cancer
Clinical Trials | 24 April 2026
Long-Term Data Show Taletrectinib Delivers High Response Rates in ROS1+ NSCLC
ONCOLife | 23 April 2026
PLN-101095 Plus Pembrolizumab Shows Durable Responses in ICI-R Solid Tumors
ONCOLife | 20 April 2026
AACR26 Data Show Multi-Biomarker MCED Approach Improves Early Cancer Detection
ONCOLife
17 April 2026
FDA Grants Breakthrough Status to First Urine-Based Multi-Cancer Early Detection Test
ONCOLife
16 April 2026
Daraxonrasib Doubles Overall Survival in Previously Treated Metastatic Pancreatic Cancer
ONCOLife
15 April 2026
Phase 2 Data Position Trastuzumab Pamirtecan as a Promising Option in Endometrial Cancer
ONCOLife
13 April 2026
MD Anderson Study Identifies DPY30 as Therapeutic Target in Pancreatic Cancer
ONCOLife
11 April 2026
New Strategy Blocks NMD, Unmasks Hidden Tumor Antigens, and Boosts Immunotherapy
ONCOLife
10 April 2026
New IHC Biomarker Test Predicts Which Gastric Cancer Patients Benefit from Immunotherapy
ONCOLife
30 March 2026
Nonviral Gene Delivery Platform Offers Promise for Cancer Treatment and Cell Therapy
ONCOLife
30 March 2026
Light-Activated Copper Nanoparticles Trigger Cuproptosis in Drug-Resistant Cancer Cells
ONCOLife
27 March 2026
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
